All Stories

  1. BioProcessNexus: An open-source platform for surrogate techno economic models
  2. Scar-free tag removal by CASPON® enzyme with broad physicochemical stability in biomanufacturing – A case study of five proteins
  3. Residue-Specific Incorporation of Noncanonical Amino Acids in Auxotrophic Hosts: Quo Vadis?
  4. Site-Directed Genome Integration via Recombinase-Mediated Cassette Exchange (RMCE) in Escherichia coli
  5. Aligning fermentation conditions with non-canonical amino acid addition strategy is essential for Nε-((2-azidoethoxy)carbonyl)-L-lysine uptake and incorporation into the target protein
  6. Manufacturing of the highly active thermophile PETases PHL7 and PHL7mut3 using Escherichia coli
  7. Purification of recombinantly produced somatostatin-28 comparing hydrochloric acid and polyethyleneimine as E. coli extraction aids
  8. A production platform for disulfide-bonded peptides in the periplasm of Escherichia coli
  9. Modifications of the 5’ region of the CASPONTM tag’s mRNA further enhance soluble recombinant protein production in Escherichia coli
  10. Understanding the mechanism of polyethyleneimine-mediated cell disintegration and protein extraction in E. coli: The role of floc network formation and PEI molecular weight
  11. RNA-seq reveals multifaceted gene expression response to Fab production in Escherichia coli fed-batch processes with particular focus on ribosome stalling
  12. Antibody fragments functionalized with non-canonical amino acids preserving structure and functionality - A door opener for new biological and therapeutic applications
  13. Polyethyleneimine efficiently extracts recombinant cytoplasmatic green fluorescent protein produced in Escherichia coli with high purity
  14. Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy
  15. Scale‐related process heterogeneities change properties of high‐cell‐density fermentation broths demonstrated with Escherichia coli B and K‐12 strains
  16. Recombinant Peptide Production Softens Escherichia coli Cells and Increases Their Size during C-Limited Fed-Batch Cultivation
  17. Development and Validation of an Artificial Neural-Network-Based Optical Density Soft Sensor for a High-Throughput Fermentation System
  18. Computational fluid dynamics simulation improves the design and characterization of a plug‐flow‐type scale‐down reactor for microbial cultivation processes
  19. CASPON platform technology: Ultrafast circularly permuted caspase-2 cleaves tagged fusion proteins before all 20 natural amino acids at the N-terminus
  20. CRISPRactivation-SMS, a message for PAM sequence independent gene up-regulation in Escherichia coli
  21. A general deep hybrid model for bioreactor systems: Combining first principles with deep neural networks
  22. Strain specific properties of Escherichia coli can prevent non-canonical amino acid misincorporation caused by scale-related process heterogeneities
  23. Model predictive control for steady-state performance in integrated continuous bioprocesses
  24. Fundamental insights in early‐stage inclusion body formation
  25. Fusion Tag Design Influences Soluble Recombinant Protein Production in Escherichia coli
  26. Strain specific properties of Escherichia coli can prevent non-canonical amino acid misincorporation caused by scale-related process heterogeneities
  27. In-Depth Characterization of a Re-Engineered Cholera Toxin Manufacturing Process Using Growth-Decoupled Production in Escherichia coli
  28. Bioprocess characterization of virus‐like particle production with the insect cell baculovirus expression system at nanoparticle level
  29. Interaction of Periplasmic Fab Production and Intracellular Redox Balance in Escherichia coli Affects Product Yield
  30. Model Transferability and Reduced Experimental Burden in Cell Culture Process Development Facilitated by Hybrid Modeling and Intensified Design of Experiments
  31. Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection
  32. Proton-transfer-reaction mass spectrometry (PTR-MS) for online monitoring of glucose depletion and cell concentrations in HEK 293 gene therapy processes
  33. PROFICS: A bacterial selection system for directed evolution of proteases
  34. Stable Sf9 cell pools as a system for rapid HIV‐1 virus‐like particle production
  35. Digital Twin Application for Model-Based DoE to Rapidly Identify Ideal Process Conditions for Space-Time Yield Optimization
  36. High shear resistance of insect cells: the basis for substantial improvements in cell culture process design
  37. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests
  38. Whole cell-based catalyst for enzymatic production of the osmolyte 2-O-α-glucosylglycerol
  39. Native Hydrophobic Interaction Chromatography Hyphenated to Multi-Angle Light Scattering Detection for In-Process Control of SARS-CoV-2 Nucleocapsid Protein Produced in Escherichia Coli
  40. Holistic view on processes is essential for efficient production process development
  41. Tunable expression rate control of a growth-decoupled T7 expression system by l-arabinose only
  42. Three-dimensional chromatography for purification and characterization of antibody fragments and related impurities from Escherichia coli crude extracts
  43. Advanced purification platform using circularly permuted caspase‐2 for affinity fusion‐tag removal to produce native fibroblast growth factor 2
  44. Quantification of glycated IgG in CHO supernatants: A practical approach
  45. High-throughput microbioreactor provides a capable tool for early stage bioprocess development
  46. A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assays
  47. Accelerating HIV‐1 VLP production using stable High Five insect cell pools
  48. Reconsider the shear paradigm - stirring and aeration strategies in cell culture processes
  49. Production of Circularly Permuted Caspase-2 for Affinity Fusion-Tag Removal: Cloning, Expression in Escherichia coli, Purification, and Characterization
  50. Adaptive Evolution in Producing Microtiter Cultivations Generates Genetically Stable Escherichia coli Production Hosts for Continuous Bioprocessing
  51. Fast and antibiotic free genome integration into Escherichia coli chromosome
  52. PEI-Mediated Transient Transfection of High Five Cells at Bioreactor Scale for HIV-1 VLP Production
  53. Hybrid Modeling and Intensified DoE: An Approach to Accelerate Upstream Process Characterization
  54. Bacteriophage Inspired Growth-Decoupled Recombinant Protein Production in Escherichia coli
  55. Extraction of recombinant periplasmic proteins under industrially relevant process conditions: Selectivity and yield strongly depend on protein titer and methodology
  56. Escherichia coli σ70 promoters allow expression rate control at the cellular level in genome-integrated expression systems
  57. Comparison of Modeling Methods for DoE‐Based Holistic Upstream Process Characterization
  58. Evaluation of screening platforms for virus-like particle production with the baculovirus expression vector system in insect cells
  59. Soft sensor based on 2D‐fluorescence and process data enabling real‐time estimation of biomass in Escherichia coli cultivations
  60. The shortcomings of accurate rate estimations in cultivation processes and a solution for precise and robust process modeling
  61. Oxygen Uptake Rate Soft-Sensing via Dynamic kLa Computation: Cell Volume and Metabolic Transition Prediction in Mammalian Bioprocesses
  62. Impact of mammalian cell culture conditions on monoclonal antibody charge heterogeneity: an accessory monitoring tool for process development
  63. Microbioreactor Cultivations of Fab‐Producing Escherichia coli Reveal Genome‐Integrated Systems as Suitable for Prospective Studies on Direct Fab Expression Effects
  64. Implementation of a Fully Automated Microbial Cultivation Platform for Strain and Process Screening
  65. Lectin bio‐layer interferometry for assessing product quality of Fc‐ glycosylated immunoglobulin G
  66. Application of the Bradford Assay for Cell Lysis Quantification: Residual Protein Content in Cell Culture Supernatants
  67. Quality by control: Towards model predictive control of mammalian cell culture bioprocesses
  68. High-level biosynthesis of norleucine in E. coli for the economic labeling of proteins
  69. Boosted structured additive regression forEscherichia colifed-batch fermentation modeling
  70. Process limitations of a whole-cell P450 catalyzed reaction using a CYP153A-CPR fusion construct expressed in Escherichia coli
  71. Fed-batch like cultivation in a micro-bioreactor: screening conditions relevant for Escherichia coli based production processes
  72. The potential of random forest and neural networks for biomass and recombinant protein modeling inEscherichia colifed-batch fermentations
  73. Finished Genome Sequence of the Laboratory Strain Escherichia coli K-12 RV308 (ATCC 31608)
  74. Finished Genome Sequence of Escherichia coli K-12 Strain HMS174 (ATCC 47011)
  75. Online prediction of product titer and solubility of recombinant proteins in Escherichia colifed-batch cultivations
  76. Preventing T7 RNA Polymerase Read-through Transcription—A Synthetic Termination Signal Capable of Improving Bioprocess Stability
  77. A Comparative Analysis of Industrial Escherichia coli K–12 and B Strains in High-Glucose Batch Cultivations on Process-, Transcriptome- and Proteome Level
  78. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production
  79. Comparative Transcription Profiling and In-Depth Characterization of Plasmid-Based and Plasmid-Free Escherichia coli Expression Systems under Production Conditions
  80. A sequence comparison and gene expression data integration add-on for the Pathway Tools software
  81. Implementation of proton transfer reaction-mass spectrometry (PTR-MS) for advanced bioprocess monitoring
  82. Soft sensors in bioprocessing: A status report and recommendations
  83. An Advanced Monitoring Platform for Rational Design of Recombinant Processes
  84. Process analytical technology (PAT) for biopharmaceuticals
  85. Marker-free plasmids for gene therapeutic applications—Lack of antibiotic resistance gene substantially improves the manufacturing process
  86. Plasmid-free T7-basedEscherichia coliexpression systems
  87. Interactive visualization of clusters in microarray data: an efficient tool for improved metabolic analysis of E. coli
  88. Model-based probe set optimization for high-performance microarrays
  89. Influence of process temperature on recombinant enzyme activity in Escherichia coli fed-batch cultures
  90. Development of an antibiotic-free plasmid selection system based on glycine auxotrophy for recombinant protein overproduction in Escherichia coli
  91. Npro fusion technology to produce proteins with authentic N termini in E. coli
  92. Using ColE1-derived RNA I for suppression of a bacterially encoded gene: implication for a novel plasmid addiction system
  93. Evaluation of the GFP signal and its aptitude for novel on-line monitoring strategies of recombinant fermentation processes
  94. Tuning the Transcription Rate of Recombinant Protein in Strong Escherichia coli Expression Systems through Repressor Titration
  95. Stabilizing plasmid copy number to improve recombinant protein production
  96. Non-invasive detection of the metabolic burden on recombinant microorganisms during fermentation processes
  97. Recombinant Expression of Alliin Lyase from Garlic (Allium sativum) in Bacteria and Yeasts